Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Unknown 3Active not recruiting 1

Sponsor Class

NIH 2UNKNOWN 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3Gynecologic 1

Conditions

Glioblastoma 44Glioma 16Melanoma 11Central Nervous System Neoplasms 11Astrocytoma 11Brain Neoplasms 10Oligodendroglioma 7Gliosarcoma 5Small Cell Lung Carcinoma 4Recurrence 3Lymphoma 3Leiomyosarcoma 3Sarcoma 2Neoplasms, Neuroepithelial 2Neoplasms 2Neoplasm Metastasis 2Ependymoma 2Diffuse Intrinsic Pontine Glioma 2Breast Neoplasms 2Uveal Melanoma 1Seizures 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma, Endometrial Stromal 1Sarcoma, Alveolar Soft Part 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Recurrent Extensive Stage Small Cell Lung Carcinoma 1Rectal Neoplasms 1Pituitary Neoplasms 1

Interventions

Temozolomide 3Doxorubicin 3Radiation Dose Hypofractionation 2nilotinib 1lentiviral minigene vaccine of COVID-19 coronavirus 1cemiplimab 1brostallicin 1Thalidomide 1Molecular Diagnostic Techniques 1Microarray Analysis 1Epirubicin 1Docetaxel 1Diathermy 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Leiomyosarcoma × Temozolomide × Clear all
NCT05204524 2022-01-24

Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma

ChineseAMS

Phase NA Unknown
28 enrolled
Sarcoma

Leiomyosarcoma

NCT00003718 2014-01-06

Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 2 Unknown
25 enrolled
GynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Ovarian Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT00033709 2014-01-06

Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma

National Cancer Institute (NCI)

Phase 2 Unknown
Sarcoma

Leiomyosarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡